FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
32 letters match. Newest first.
-
DrugsSnugZ USA, Inc.
SnugZ USA, an OTC drug maker in West Jordan, Utah, was cited for releasing drugs after retesting failed batches until they passed.
High risk -
DrugsFresenius Medical Care AG & Co. KGaA
Fresenius Medical Care's Ogden, Utah plant failed to investigate leaking peritoneal dialysis bags, leading to a 2026 recall.
High risk -
DrugsExcelvision - Fareva
FDA warned Excelvision-Fareva after a 2026 inspection found inadequate contamination investigations and aseptic failures for sterile drugs.
High risk -
DevicesHappiest Baby, Inc.
FDA says Happiest Baby marketed unapproved SNOO sleep sacks and hospital bundle and mishandled complaints.
High risk -
DrugsCareFusion 213, LLC
FDA warns CareFusion 213 over inadequate investigations and contamination controls at its El Paso sterile drug plant.
High risk -
DrugsCohance Lifesciences Limited
Cohance Lifesciences, a finished-drug maker, was cited for inadequate investigations and dirty shared equipment that caused cross-contamination.
High risk -
DevicesUnomedical Device S.A. de C.V.
FDA warns Unomedical over insulin infusion sets with unvalidated leak tests and unreported serious injuries.
High risk -
DrugsDarmerica, LLC
FDA warns Darmerica over manufacturing-quality violations and mislabeled drug ingredients, including retatrutide.
High risk -
DevicesEnvoy Medical Inc.
Envoy Medical in Saint Paul, MN was cited for quality system failures in making its Esteem II Implantable Hearing System, including slow complaint investigations and missed cleanroom contamination risks.
High risk -
DrugsJanssen Vaccines Corp., A Johnson & Johnson Company
FDA warned Janssen Vaccines over inadequate investigations of stopper complaints and missed regulatory notifications for its injection drug.
Medium -
DevicesReset Technology Corporation
FDA warns Reset Technology about missing validation and complaint handling for ResetSmile dental devices.
High risk -
DrugsExcelvision Fareva
Excelvision Fareva, a sterile drug manufacturer, was cited for inadequate mold/black-speck complaint investigations and aseptic contamination controls.
High risk -
DevicesNoah Medical Corporation
FDA warns Noah Medical of San Jose, CA over quality system failures and missed injury reports for its Galaxy bronchoscopes.
High risk -
DrugsShree Jaya Laboratories PVT. LTD.
FDA warned Shree Jaya Laboratories after an inspection found CGMP deviations in API and intermediate manufacturing, including dirty equipment and torn batch records.
High risk -
DrugsIndoco Remedies Limited
FDA warned Indoco Remedies over manufacturing quality failures at its Goa plant, including unreliable microbial testing and aseptic processing deficiencies.
High risk -
DrugsSombra Cosmetics, Inc.
FDA warned Sombra Cosmetics of OTC drug CGMP violations, including inadequate water controls and component testing.
High risk -
DrugsBrands International Corporation
Brands International, a Canadian drug manufacturer, limited an FDA inspection and had manufacturing quality violations including mold contamination.
High risk -
DrugsAzurity Pharmaceuticals, Inc.
FDA warned Azurity Pharmaceuticals over unapproved FIRST drug kits and manufacturing quality failures at its Wilmington, MA plant.
High risk -
DevicesGlobus Medical, Inc.
FDA warns Globus Medical over Excelsius GPS robot-related misplaced screw complaints and late or missing device reports.
High risk -
DevicesTrexo Robotics Holdings Inc.
FDA warns Trexo Robotics over unapproved robotic gait-training legs for children and design-control gaps at its Canadian plant.
High risk -
DrugsWestwood Laboratories LLC
FDA warned Westwood Laboratories after an inspection found inadequate investigations, raw material testing, lab controls, and water/cleaning controls for OTC drugs.
High risk -
DrugsSichuan Deebio Pharmaceutical Co. Ltd.
FDA warns Sichuan Deebio Pharmaceutical over API manufacturing and data-integrity failures.
High risk -
DevicesOlympus Medical Systems Corp.
FDA warned Olympus Medical Systems about endoscope accessories for quality-system, complaint, packaging-seal, and reporting failures.
High risk -
DrugsMD Pharmaceutical Supply, LLC
FDA warns MD Pharmaceutical Supply over API repackaging failures, including redistributing a returned lot and uncontrolled cross-contamination risks.
High risk -
FoodNutritional Laboratories International, Inc. DBA Elite One Source Nutritional Services, Inc.
FDA warns Nutritional Laboratories International over CGMP violations and misbranded dietary supplement labels found after 2021 inspection.
Medium -
DevicesZyno Medical LLC
FDA warns Zyno Medical over infusion pump and administration set quality violations and unapproved set changes.
High risk -
DrugsJost Chemical Co.
Jost Chemical Co. made active drug ingredients under CGMP deviations, including mold contamination and inadequate investigations.
High risk -
DrugsBi-Coastal Pharma International
FDA warned Bi-Coastal Pharma International about adulterated drugs due to poor complaint handling, quality-unit oversight, batch release, and training.
High risk -
DrugsAire-Master of America, Inc.
FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.
High risk -
DrugsVi-Jon, LLC
FDA cited Vi-Jon for manufacturing-rule violations after finding microbial water contamination, leaks, weak investigations, and data-integrity failures in OTC drugs and cosmetics.
High risk -
DevicesDSAART, LLC. dba Alpha Aesthetics
FDA warned Alpha Aesthetics after inspection found unvalidated sterilization and manufacturing, poor complaint handling, and missed injury reports for silicone implants.
High risk -
DevicesDeVilbiss Healthcare LLC
FDA cites DeVilbiss over oxygen concentrator overheating and late medical device reports.
High risk